Health

FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable Biosimilar to NovoLog

DailyTrendDailyTrend
Jul 16, 2025 - 01:00
 0  0
FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable Biosimilar to NovoLog
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India: July 15, 2025 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced that the U.S...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

The 2 Beliefs Driving Conservative Health Care Policy

DailyTrend Aug 1, 2025  0  0

Bird Flu May Be Airborne on Dairy Farms, Scientists Report

Bird Flu May Be Airborne on Dairy Farms, Scientists Report

DailyTrend Aug 4, 2025  0  0

Radioactive Wasps Found at Nuclear Site in South Carolina Could Be a ‘Red Flag,’ Expert Says

Radioactive Wasps Found at Nuclear Site in South Caroli...

DailyTrend Aug 1, 2025  0  0

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the F...

DailyTrend Jul 30, 2025  0  0

Major Study on Transgender Youth Health Care to Begin in U.K.

Major Study on Transgender Youth Health Care to Begin i...

DailyTrend Jul 31, 2025  0  0

FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults

FDA Approves Vostally (ramipril) Oral Solution for the ...

DailyTrend Aug 4, 2025  0  0